Former unicorn genetics startup Human Longevity loses its horn
The company's valuation has declined 80 percent, from a $1.6 billion peak to $310 million, according to The Wall Street Journal.
Human Longevity accuses its founder Craig Venter of stealing trade secrets
Genomic sequencing legend Craig Venter now stands accused of stealing trade secrets and attempting to poach employees by the very company he founded.
presented by
A Path to Healing: Discovering Arizona’s PTSD Treatment Centers
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
Venter steps down as CEO of Human Longevity
J. Craig Venter will step down as CEO of his ambitious genomics-driven biotech Human Longevity, effective January 9.